Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021

Go back to Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021

Merck (MRK) PT Raised to $90 at Morgan Stanley on Gardasil Strength

October 29, 2021 8:46 AM EDT

Morgan Stanley analyst Matthew Harrison raised the price target on Merck (NYSE: MRK) to $90.00 (from $88.00) while maintaining a Equalweight rating after 3Q total revenue beat expectations driven primarily by Gardasil sales due to strong global demand and increased supply. Management expects robust... More